Table 3.
Surgical | Conventional | Difference | |
---|---|---|---|
Undiscounted | |||
Years in diabetes remission | 11.4 | 2.1 | 9.4 |
Total life-years | 32.1 | 30.5 | 1.6 |
QALYs | 24.9 | 22.6 | 2.3 |
Discounted at 3% for both costs and benefits | |||
Costs (AUD) | |||
2-year RCT intervention | 13,383 | 3,397 | 9,987 |
Surgical intervention maintenance | 6,477 | 6,477 | |
Surgical intervention complications | 1,768 | 1,768 | |
Type 2 diabetes remission—monitoring costs | 16,479 | 2,874 | 13,605 |
Health care costs to treat type 2 diabetes | 60,824 | 95,105 | (34,281) |
Total cost | 98,931 | 101,376 | (2,444) |
Effectiveness | |||
Total life-years | 20.0 | 19.2 | 0.7 |
QALYs | 15.7 | 14.5 | 1.2 |
Cost-effectiveness | |||
Cost per life-year gained | Dominant | ||
Cost per QALY | Dominant | ||
Probability of dominance | 57% | ||
Probability of cost-effectiveness at willingness-to-pay threshold | 98% |
Dominant: generates health care savings and health benefits. Willingness–to–pay threshold, 50,000 AUD per QALY.